Yang, Wenying http://orcid.org/0000-0002-7997-9404
Akhtar, Shahid
Franek, Edward
Haluzík, Martin
Hirose, Takahisa
Kalyanam, Balamurali
Kar, Soumitra
Wu, Ted
Gogas Yavuz, Dilek
Unnikrishnan, Ambika Gopalakrishnan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Insulin Degludec/Insulin Aspart (IDegAsp) Twice Daily (BID) vs. Biphasic Insulin Aspart 30 (BIAsp 30) BID—A Randomized Trial in Chinese Patients with Type 2 Diabetes
https://doi.org/10.2337/db18-91-lb
Documents that mention this clinical trial
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes
https://doi.org/10.1007/s13300-016-0213-8
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Documents that mention this clinical trial
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
https://doi.org/10.1007/s13300-021-01196-7
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 10 September 2021
Accepted: 22 December 2021
First Online: 19 January 2022